Patents Assigned to Baylor
  • Patent number: 11459565
    Abstract: Embodiments of the disclosure include methods and compositions for the renewal of cardiomyocytes by targeting the Hippo pathway. In particular embodiments, an individual with a need for cardiomyocyte renewal is provided an effective amount of a shRNA molecule that targets the Sav1 gene. Particular shRNA sequences are disclosed.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: October 4, 2022
    Assignee: BAYLOR COLLEGE OF MEDICINE
    Inventors: James F. Martin, Yuka Morikawa, Todd Ryan Heallen, John Leach
  • Patent number: 11458168
    Abstract: Embodiments of the disclosure include methods and compositions for producing NKT cells effective for immunotherapy and also methods and compositions for providing an effective amount of NKT cells to an individual in need of immunotherapy. In specific embodiments, the NKT cells are CD62L+ and have been exposed to one or more costimulatory agents to maintain CD62L expression. The NKT cells may be modified to incorporate a chimeric antigen receptor, in some cases.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: October 4, 2022
    Assignee: Baylor College of Medicine
    Inventors: Leonid S. Metelitsa, Amy N. Courtney, Gengwen Tian
  • Publication number: 20220297820
    Abstract: The present disclosure provides a rotating propeller design that maintains a high efficiency and reduces noise. The design provides an unloaded tip zone of positive lift starting prior to an end of the tip with negligible, if any, positive lift that is counterintuitive to the purpose of a propeller. The unloaded tip zone decreases the strength of a tip vortex and reduces induced drag. The result is a significant reduction in noise while maintaining substantially high mechanical efficiency, even with an optional increase in RPM to compensate for the reduced lift without requiring a longer propeller. At least one propeller design can break the beta angle from the propeller hub with a different beta angle at a first location from the hub and then also break the beta angle at a second location further from the hub into the unloaded tip zone to form a double break propeller.
    Type: Application
    Filed: March 21, 2022
    Publication date: September 22, 2022
    Applicants: BAYLOR UNIVERSITY, WISNIEWSKI ENTERPRISES
    Inventors: Kenneth W. VAN TREUREN, Charles F. WISNIEWSKI
  • Patent number: 11448820
    Abstract: The present disclosure provides an optical waveguide design of a fiber modified with a thin layer of epsilon-near-zero (ENZ) material. The design results in an excitation of a highly confined waveguide mode in the fiber near the wavelength where permittivity of thin layer approaches zero. Due to the high field confinement within thin layer, the ENZ mode can be characterized by a peak in modal loss of the hybrid waveguide. Results show that such in-fiber excitation of ENZ mode is due to the coupling of the guided fundamental core mode to the thin-film ENZ mode. The phase matching wavelength, where the coupling takes place, varies depending on the refractive index of the constituents. These ENZ nanostructured optical fibers have many potential applications, for example, in ENZ nonlinear and magneto-optics, as in-fiber wavelength-dependent filters, and as subwavelength fluid channel for optical and bio-photonic sensing.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: September 20, 2022
    Assignee: Baylor University
    Inventors: Ho Wai Howard Lee, Khant Minn, Jingyi Yang, Oleksiy Anopchenko
  • Publication number: 20220290147
    Abstract: Compositions and methods relating to regulation of gene expression are described. In some embodiments, the present disclosure provides compositions and methods for the regulation of gene expression using nucleic acid constructs. In some embodiments, the present disclosure recognizes the utility of alternative splicing in regulation of gene expression in a nucleic acid construct. In some embodiments, the present disclosure recognizes the utility of regulating gene expression utilizing ligand-binding aptamers.
    Type: Application
    Filed: August 28, 2020
    Publication date: September 15, 2022
    Applicants: Baylor College of Medicine, Baylor College of Medicine
    Inventors: Laising Yen, Liming Luo, Jocelyn Duen-Ya Jea
  • Patent number: 11441990
    Abstract: The present disclosure provides a low-cost and accurate rheometer system and method capable of determining melt flow rheological properties of polymers, such as from Fused Filament Fabrication (“FFF”) polymeric materials. The device can include a filament feeding system, liquefier for filament melting, force transducer for measuring filament feeding force, and a temperature control system for controlling polymer melt temperatures. An electronic control system can capture data and manage operations. The system can measure a filament velocity and filament force required to extrude the FFF filament for printing. The filament velocity and force data can be used to compute data sets of melt volumetric flow relative to pressure drop across a FFF nozzle.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: September 13, 2022
    Assignee: Baylor University
    Inventors: Douglas E. Smith, Jingdong Chen
  • Publication number: 20220284288
    Abstract: The present disclosure relates to machine-learning generalization, and in particular to techniques for regularizing machine-learning The present disclosure relates to machine-learning generalization, and in particular to techniques for regularizing machine-learning models using biological systems (e.g. brain data) to engineer machine-learning-algorithms that can generalize better. Particularly, aspects are directed to a computer implemented method that includes measuring a plurality of biological responses (e.g. neural responses to stimuli or other variables such body movements); generating data (e.g. responses to stimuli) using the predictive model which can denoise biological data and extract task relevant information; scaling and transforming these predictions (e.g. measure representational similarities between stimuli); and using the biologically derived data to regularize machine-learning-algorithms.
    Type: Application
    Filed: September 24, 2020
    Publication date: September 8, 2022
    Applicants: BAYLOR COLLEGE OF MEDICINE, UNIVERSITY OF TUBINGEN
    Inventors: ANDREAS TOLIAS, ZHE LI, ZACHARY PITKOW, JOSUE ORTEGA CARO, ANKIT PATEL, JACOB REIMER, MATTHIAS BETHGE, FABIAN SINZ
  • Patent number: 11436967
    Abstract: Systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
    Type: Grant
    Filed: March 24, 2022
    Date of Patent: September 6, 2022
    Assignee: BAYLOR UNIVERSITY
    Inventors: Gary B. Mandle, James M. DeFilippis
  • Patent number: 11428693
    Abstract: The present disclosure relates to methods for screening test samples or substances that are capable of inducing or reducing nucleolar hypertrophy in cancer cells. The present disclosure further provides methods of contacting isolated cancer cells with a test sample or a substance that can induce nucleolar hypertrophy in a cancer cell. The present disclosure further provides methods for contacting an isolated cancer cell characterized by nucleolar hypertrophy with a test sample or substance that can reduce the nucleolar hypertrophy. One benefit to the method of screening disclosed herein can be the identification of test samples or substances capable of reducing nucleolar hypertrophy. Another benefit to the method of screening disclosed herein can be the identification of those combinations of test samples, substances, or combinations or series thereof, which are suitable or optimal for treating specific cancers in patients.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: August 30, 2022
    Assignee: Baylor College of Medicine
    Inventor: Tattym E. Shaiken
  • Patent number: 11421229
    Abstract: Embodiments of the disclosure include methods and compositions for in situ cardiac cell regeneration, including transdifferentiation of cardiac cells to cardiomyocytes. In particular embodiments, in situ cardiac cell regeneration encompasses delivery of p63 shRNA and one or both of Hand2 and myocardin, and in specific embodiments further includes one or more of Gata4, Mef2c, and Tbx5. In specific aspects of the disclosure, adult cardiac fibroblasts are reprogrammed into cardiomyocytes using viral vectors that harbor p63 shRNA and one or both of the transcription factors Hand2 and myocardin.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: August 23, 2022
    Assignee: Baylor College of Medicine
    Inventors: Vivekkumar B. Patel, Hongran Wang, Vivek P. Singh, Erin Lynn Reineke, Megumi Mathison, Austin J. Cooney, Todd Rosengart
  • Publication number: 20220257654
    Abstract: Embodiments of the disclosure include methods of identifying and selecting suitable donors for use in constructing donor minibanks of antigen-specific T cell lines; donor minibanks of antigen-specific T cell lines; and donor banks made up of a plurality of such minibanks. The present disclosure includes methods of treating a disease or condition comprising administering at least one antigen-specific T cell line from such a donor minibank or donor bank to patient (e.g., who has received transplanted material from a transplant donor in a transplant procedure), and methods for selecting the best HLA-matched antigen-specific T cell line in the donor minibank for a particular patient.
    Type: Application
    Filed: July 29, 2020
    Publication date: August 18, 2022
    Applicant: BAYLOR COLLEGE OF MEDICINE
    Inventors: Juan Fernando VERA VALDES, Ann Marie LEEN, Ifigeneia TZANNOU
  • Publication number: 20220254295
    Abstract: Systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
    Type: Application
    Filed: April 22, 2022
    Publication date: August 11, 2022
    Applicant: Baylor University
    Inventors: Gary B. Mandle, James M. DeFilippis, Mitchell J. Bogdanowicz, Corey P. Carbonara, Michael F. Korpi
  • Patent number: 11406688
    Abstract: The present invention includes compositions and methods for treating arthritic joints found in patients with autoinflammation, e.g., systemic onset juvenile idiopathic arthritis, by administering at the site of inflammation a therapeutically effective amount of at least one agent that reduces or blocks the bioavailability of interleukin-1?.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: August 9, 2022
    Assignee: BAYLOR RESEARCH INSTITUTE
    Inventors: Jacques F. Banchereau, Maria Virginia Pascual
  • Patent number: 11410593
    Abstract: The present invention includes systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
    Type: Grant
    Filed: February 11, 2022
    Date of Patent: August 9, 2022
    Assignee: BAYLOR UNIVERSITY
    Inventors: Mitchell J. Bogdanowicz, Corey P. Carbonara, Michael F. Korpi, James M. DeFilippis, Gary B. Mandle
  • Patent number: 11403987
    Abstract: Systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
    Type: Grant
    Filed: February 14, 2022
    Date of Patent: August 2, 2022
    Assignee: BAYLOR UNIVERSITY
    Inventors: Gary B. Mandle, James M. DeFilippis, Mitchell J. Bogdanowicz, Corey P. Carbonara, Michael F. Korpi
  • Publication number: 20220233616
    Abstract: Methods of treating a cancer, comprising administering to a subject: (i) a virus comprising nucleic acid encoding an antigen-binding molecule comprising: (a) an antigen-binding moiety specific for an immune cell surface molecule, and (b) an antigen-binding moiety specific for a cancer cell antigen; and (ii) an oncolytic virus, and/or (iii) at least one cell comprising a chimeric antigen receptor (CAR) specific for a cancer cell antigen are disclosed. Also disclosed are articles and compositions for use in such methods.
    Type: Application
    Filed: October 25, 2019
    Publication date: July 28, 2022
    Applicant: Baylor College of Medicine
    Inventor: Masataka Suzuki
  • Patent number: 11396645
    Abstract: Embodiments of the disclosure concern systems, methods, and/or compositions for cultivation of mammalian viruses, including at least human noroviruses and sapoviruses within the Caliciviridae family of viruses. The ex vivo culture systems include intestinal enteroids in combination with bile or a functionally active fraction or component thereof. In specific embodiments, the culture system is utilized to test inactivation compounds for therapeutic or environmental efficacy and to test contaminated comestibles and/or environmental entities for determination of the presence of infectious virus. Furthermore, antiviral compositions may be tested using systems of the disclosure, including drugs, small molecule inhibitors, and biologics such as neutralizing monoclonal antibodies.
    Type: Grant
    Filed: August 24, 2020
    Date of Patent: July 26, 2022
    Assignee: Baylor College of Medicine
    Inventors: Mary K. Estes, David Graham, Robert Legare Atmar, Sue Ellen Crawford, Khalil Ettayebi, Kosuke Murakami
  • Publication number: 20220226448
    Abstract: Methods and compositions using artificial antigen presenting cells in immunotherapy. The artificial antigen presenting cells comprise substrate particles bound to endogenous MHC-peptide complexes obtained from one or more cells. Methods include administering the artificial antigen presenting cells to a patient to activate antigen-specific T cells.
    Type: Application
    Filed: May 22, 2020
    Publication date: July 21, 2022
    Applicant: BAYLOR RESEARCH INSTITUTE
    Inventors: Botond Z. IGYÁRTÓ, Qingtai SU
  • Publication number: 20220227750
    Abstract: Embodiments of the invention include methods of preventing and/or reducing the risk or severity of an allergic reaction in an individual. In some embodiments, particular small molecules are employed for prevention and/or reduction in the risk or severity of anaphylaxis. In at least particular cases, the small molecules are inhibitors of STAT3. In some cases, the small molecule comprises N-(1?,2-dihydroxy-1,2?-binaphthalen-4?-yl)-4-methoxybenzenesulfonamide.
    Type: Application
    Filed: January 27, 2022
    Publication date: July 21, 2022
    Applicants: Baylor College of Medicine, The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: David J. Tweardy, Moses M. Kasembeli, Marvin X. Xu, Josh Milner, Claire Elizabeth Bocchini
  • Publication number: 20220230577
    Abstract: Systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
    Type: Application
    Filed: March 24, 2022
    Publication date: July 21, 2022
    Applicant: Baylor University
    Inventors: Mitchell J. Bogdanowicz, Corey P. Carbonara, Michael F. Korpi, James M. DeFilippis, Gary B. Mandle